SCHEMBL1462040

SCHEMBL1462040

CC(C(=O)O)C(=O)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-63012341-A None JP disclosed
CN-119072546-A Transgenic soybean strain GM_CSM63714, detection method and application thereof 孟山都技术公司 2024-12-03 CN disclosed
US-10717738-B2 Pyrimidinone and its derivatives inhibiting factor XIa ONO PHARMACEUTICAL CO., LTD. (JP) 2020-07-21 US disclosed
EP-3290413-B9 PYRIDINONE AND PYRIMIDINONE DERIVATIVES AS FACTOR XIA INHIBITORS ONO PHARMACEUTICAL CO (JP) 2020-04-29 EP disclosed
EP-3290413-B1 PYRIDINONE AND PYRIMIDINONE DERIVATIVES AS FACTOR XIA INHIBITORS ONO PHARMACEUTICAL CO (JP) 2019-11-13 EP disclosed
EP-3290413-A1 PYRIDINONE AND PYRIMIDINONE DERIVATIVES AS FACTOR XIA INHIBITORS ONO Pharmaceutical Co., Ltd. (JP) 2018-03-07 EP disclosed
EP-2794597-B1 PYRIDINONE AND PYRIMIDINONE DERIVATIVES AS FACTOR XIA INHIBITORS ONO PHARMACEUTICAL CO (JP) 2017-11-15 EP disclosed
US-20170305917-A1 COMPOUNDS ONO PHARMACEUTICAL CO., LTD. (JP) 2017-10-26 US disclosed
US-9732085-B2 Pyridinone and pyrimidinone derivatives as factor Xia ONO PHARMACEUTICAL CO., LTD. (JP) 2017-08-15 US disclosed
US-9102592-B2 Intermediate compounds and processes for the preparation of quinoline derivatives such as laquinimod sodium MAPI PHARMA LTD. (IL) 2015-08-11 US disclosed
WO-1995004057-A1 TRICYCLIC INHIBITORS OF THE GPIIbIIIa RECEPTOR GENENTECH, INC. (US) 1995-02-09 WO disclosed
US-5232462-A Lightfast, colorfast CIBA-GEIGY CORPORATION (US) 1993-08-03 US disclosed
US-5177071-A 1,4-BENZODIAZEPINES WITH 6-MEMBERED HETEROCYCLIC RINGS TO TREAT PANIC AND ANXIETY DISORDER MERCK & CO., INC. (US) 1993-01-05 US disclosed
EP-0519678-A2 1,4-Benzodiazepines with 6-membered heterocyclic rings MERCK & CO. INC. (US) 1992-12-23 EP disclosed
US-4816499-A Porous inorganic particles modified with amino and carboxyl groups DIRECTOR GENERAL OF AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 1989-03-28 US disclosed
EP-0272868-A1 1,4-Benzodiazepines with 6-membered heterocyclic rings MERCK & CO. INC. (US) 1988-06-29 EP disclosed
JP-S6312341-A METHOD FOR REFORMING POROUS SUBSTANCE AGENCY OF IND SCIENCE & TECHNOL 1988-01-19 JP disclosed
US-4336380-A FOR USE AS HYPOTENSIVE AGENTS HOFFMANN-LA ROCHE INC. (US) 1982-06-22 US disclosed
US-4329473-A HYPOTENSIVE AGENTS SRI INTERNATIONAL 1982-05-11 US disclosed
US-4276417-A TREATMENT OF VASCULAR-CONDITION HYPERTENSION HOFFMANN-LA ROCHE INC. (US) 1981-06-30 US disclosed